期刊
CNS NEUROSCIENCE & THERAPEUTICS
卷 18, 期 7, 页码 547-557出版社
WILEY
DOI: 10.1111/j.1755-5949.2012.00316.x
关键词
Amyotrophic lateral sclerosis; G93A mice; Lifespan; Motor performance; Paw grip endurance; Vitamin D
资金
- Natural Sciences and Engineering Research Council of Canada
- Faculty of Health-York University
Background Vitamin D has antioxidant, anti-inflammatory, and neuroprotective properties, and may mitigate amyotrophic lateral sclerosis (ALS) pathology. Aims To determine the effects of dietary vitamin D3 (D3) at 10-fold the adequate intake (AI) on functional and disease outcomes and lifespan in the transgenic G93A mouse model of ALS. Methods Starting at age 40 days, 32 G93A mice (21 M, 11 F) were provided ad libitum with either an adequate (AI; 1 IU/g feed) or high (HiD; 10 IU/g feed) D3 diet. Differences were considered significant at P= 0.10, as this was a pilot study. Results For paw grip endurance, HiD mice had a 7% greater score between 60133 d versus AI mice (P= 0.074). For motor performance, HiD mice had a 22% greater score between 60133 days (P= 0.074) versus AI mice due to changes observed in male mice, where HiD males had a 33% greater score (P= 0.064) versus AI males. There were no significant diet differences in disease onset, disease progression, or lifespan. Conclusion Although disease outcomes were not affected, D3 supplementation at 10-fold the AI improved paw grip endurance and motor performance in the transgenic G93A mouse model of ALS, specifically in males.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据